Tortoise Investment Management’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,000
| Closed | -$31.4K | – | 1286 |
|
|
2025
Q1 | $31.4K | Hold |
10,000
| – | – | ﹤0.01% | 436 |
|
|
2024
Q4 | $43.4K | Hold |
10,000
| – | – | ﹤0.01% | 439 |
|
|
2024
Q3 | $26.7K | Hold |
10,000
| – | – | ﹤0.01% | 514 |
|
|
2024
Q2 | $22.2K | Hold |
10,000
| – | – | ﹤0.01% | 514 |
|
|
2024
Q1 | $53.4K | Sell |
10,000
-5,000
| -33% | -$26.7K | 0.01% | 374 |
|
|
2023
Q4 | $22.2K | Hold |
15,000
| – | – | ﹤0.01% | 465 |
|
|
2023
Q3 | $20.9K | Hold |
15,000
| – | – | ﹤0.01% | 460 |
|
|
2023
Q2 | $22.1K | Hold |
15,000
| – | – | ﹤0.01% | 453 |
|
|
2023
Q1 | $24.8K | Hold |
15,000
| – | – | ﹤0.01% | 432 |
|
|
2022
Q4 | $21K | Hold |
15,000
| – | – | ﹤0.01% | 448 |
|
|
2022
Q3 | $23K | Hold |
15,000
| – | – | ﹤0.01% | 417 |
|
|
2022
Q2 | $33K | Hold |
15,000
| – | – | 0.01% | 343 |
|
|
2022
Q1 | $37K | Hold |
15,000
| – | – | 0.01% | 337 |
|
|
2021
Q4 | $90K | Hold |
15,000
| – | – | 0.02% | 229 |
|
|
2021
Q3 | $100K | Sell |
15,000
-5,000
| -25% | -$33.3K | 0.02% | 198 |
|
|
2021
Q2 | $133K | Sell |
20,000
-5,000
| -20% | -$33.3K | 0.03% | 183 |
|
|
2021
Q1 | $232K | Hold |
25,000
| – | – | 0.05% | 142 |
|
|
2020
Q4 | $450K | Hold |
25,000
| – | – | 0.1% | 103 |
|
|
2020
Q3 | $355K | Hold |
25,000
| – | – | 0.09% | 109 |
|
|
2020
Q2 | $125K | Buy |
+25,000
| New | +$125K | 0.03% | 166 |
|